How to Approach RANZCP MEQ Depression Cases

Access the full MEQ and MEQ Marking course here: https://psychscene.co/442K4n2 Preparing for the RANZCP MEQ exam? In this video, Dr Sanil Rege explains how to approach depression cases in the MEQ by distinguishing dopaminergic and serotonergic depression, a high-yield concept that directly shapes antidepressant selection and case interpretation. The video focuses on how symptom pattern, severity, medication dose, limbic activation, and hormonal factors can help candidates think beyond generic depression labels. It also clarifies why broad-spectrum antidepressants, augmentation strategies, and mixed-feature clues are so important in consultant-level MEQ reasoning. This is particularly useful for psychiatry trainees preparing for the MEQ, long case, or clinical exams, where examiners expect clear reasoning around depressive subtypes, antidepressant choice, and the broader neurobiological formulation of mood disorders. In this video, you’ll learn: How to distinguish dopaminergic from serotonergic depression in MEQ cases Why severe anhedonia, psychomotor retardation, and neurocognitive symptoms point towards broader-spectrum treatment How antidepressant selection changes across SNRIs, mirtazapine, tricyclics, MAOIs, agomelatine, and vortioxetine Why limbic activation matters in mixed features, hypomania, mania, and agitated depression How estrogen, thyroid, and hormonal factors can change antidepressant response and augmentation strategy Relevant for: RANZCP MEQ preparation, psychiatry exam preparation, depression cases in the MEQ, antidepressant selection, dopaminergic depression, serotonergic depression, mixed features, mood disorders, and consultant-level psychiatric reasoning. #Psychiatry #MEQ #Depression